ATE471724T1 - Radioaktiv markierte verbindungen auf peptidbasis und ihre verwendung - Google Patents

Radioaktiv markierte verbindungen auf peptidbasis und ihre verwendung

Info

Publication number
ATE471724T1
ATE471724T1 AT07860908T AT07860908T ATE471724T1 AT E471724 T1 ATE471724 T1 AT E471724T1 AT 07860908 T AT07860908 T AT 07860908T AT 07860908 T AT07860908 T AT 07860908T AT E471724 T1 ATE471724 T1 AT E471724T1
Authority
AT
Austria
Prior art keywords
based compounds
labeled peptide
radioactively labeled
diseases
compounds
Prior art date
Application number
AT07860908T
Other languages
English (en)
Inventor
Torgrim Engell
Steven Fairway
Ingrid Henriksen
Original Assignee
Ge Healthcare As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare As filed Critical Ge Healthcare As
Application granted granted Critical
Publication of ATE471724T1 publication Critical patent/ATE471724T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/13—Labelling of peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Reproductive Health (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT07860908T 2006-12-11 2007-12-11 Radioaktiv markierte verbindungen auf peptidbasis und ihre verwendung ATE471724T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86938206P 2006-12-11 2006-12-11
PCT/NO2007/000434 WO2008072973A2 (en) 2006-12-11 2007-12-11 Radiolabelled peptide based compounds and uses thereof

Publications (1)

Publication Number Publication Date
ATE471724T1 true ATE471724T1 (de) 2010-07-15

Family

ID=39252990

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07860908T ATE471724T1 (de) 2006-12-11 2007-12-11 Radioaktiv markierte verbindungen auf peptidbasis und ihre verwendung

Country Status (15)

Country Link
US (1) US20100322857A1 (de)
EP (1) EP2101826B1 (de)
JP (1) JP2010512310A (de)
KR (1) KR20090097868A (de)
CN (2) CN102321154A (de)
AT (1) ATE471724T1 (de)
AU (1) AU2007332210A1 (de)
BR (1) BRPI0720257A2 (de)
CA (1) CA2671564A1 (de)
DE (1) DE602007007362D1 (de)
ES (1) ES2346595T3 (de)
MX (1) MX2009006028A (de)
PL (1) PL2101826T3 (de)
RU (1) RU2009119917A (de)
WO (1) WO2008072973A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011027584A1 (ja) * 2009-09-04 2011-03-10 国立大学法人京都大学 膵島イメージング用分子プローブ及びその使用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE188387T1 (de) * 1991-02-08 2000-01-15 Diatide Inc Technetium-99m markierte polypeptide zur bildformung
KR100866666B1 (ko) * 2000-04-12 2008-11-04 지이 헬스케어 에이에스 펩티드 기재 화합물
HU230901B1 (hu) * 2001-07-10 2019-01-28 Ge Healthcare Limited Peptidalapú vegyületek és ezeket tartalmazó gyógyszerkészítmények
GB0116815D0 (en) * 2001-07-10 2001-08-29 Nycomed Amersham Plc Improved chelator conjugates
NO20030115D0 (no) * 2003-01-09 2003-01-09 Amersham Health As Kontrastmiddel
GB0305704D0 (en) * 2003-03-13 2003-04-16 Amersham Plc Radiofluorination methods

Also Published As

Publication number Publication date
DE602007007362D1 (de) 2010-08-05
BRPI0720257A2 (pt) 2014-02-25
MX2009006028A (es) 2009-06-17
CN102321154A (zh) 2012-01-18
CN101563108B (zh) 2012-07-18
CN101563108A (zh) 2009-10-21
US20100322857A1 (en) 2010-12-23
ES2346595T3 (es) 2010-10-18
PL2101826T3 (pl) 2010-11-30
KR20090097868A (ko) 2009-09-16
JP2010512310A (ja) 2010-04-22
CA2671564A1 (en) 2008-06-19
EP2101826A2 (de) 2009-09-23
AU2007332210A1 (en) 2008-06-19
EP2101826B1 (de) 2010-06-23
WO2008072973A2 (en) 2008-06-19
RU2009119917A (ru) 2011-01-20
WO2008072973A3 (en) 2009-05-22

Similar Documents

Publication Publication Date Title
Sellmyer et al. Bacterial infection imaging with [18F] fluoropropyl-trimethoprim
Mitran et al. Bispecific GRPR-antagonistic anti-PSMA/GRPR heterodimer for PET and SPECT diagnostic imaging of prostate cancer
Buder et al. Somatostatin receptor expression in Merkel cell carcinoma as target for molecular imaging
Wang et al. A new optical and nuclear dual-labeled imaging agent targeting interleukin 11 receptor alpha-chain
Nock et al. [99mTc] Tc-DB15 in GRPR-targeted tumor imaging with SPECT: from preclinical evaluation to the first clinical outcomes
DE602004023092D1 (de) Bildgebende agentien auf basis bizyklischer peptide
CY1119367T1 (el) Παραγοντες προσδεσης του psma και χρησεις αυτων
NO20071880L (no) Diagnostic Compounds
Kaloudi et al. NeoBOMB1, a GRPR-antagonist for breast cancer theragnostics: First results of a preclinical study with [67Ga] NeoBOMB1 in T-47D cells and tumor-bearing mice
BR0210886A (pt) Composto, composição farmacêutica, uso de um composto, e, métodos de geração de imagens, de monitoração do efeito do tratamento de um corpo humano ou animal com uma droga para combater uma condição associada com câncer e de tratamento de câncer ou de uma doença relacionada em um corpo humano ou animal
ATE434445T1 (de) Bei tumorbildgebung und krebsbehandlung als trägermittel für pharmazeutische verbindungen eingesetzte autoantikörper
DE602004016010D1 (de) Verfahren zur ä11cü-radiomarkierung von phenthiazin und phenothiazinartige verbindungen
Rizvi et al. Emerging trends of receptor-mediated tumor targeting peptides: A review with perspective from molecular imaging modalities
Bandara et al. Matched-pair, 86Y/90Y-labeled, bivalent RGD/bombesin antagonist,[RGD-Glu-[DO3A]-6-Ahx-RM2], as a potential theranostic agent for prostate cancer
EP2291075A4 (de) Gastrin freisetzende peptid-verbindungen
Fani et al. Selection of the first 99mTc-labelled somatostatin receptor subtype 2 antagonist for clinical translation—Preclinical assessment of two optimized candidates
Hungnes et al. One-step, kit-based radiopharmaceuticals for molecular SPECT imaging: a versatile diphosphine chelator for 99m Tc radiolabelling of peptides
Love et al. 5. Utility of F-18 FDG imaging for diagnosing the infected joint replacement
Nock et al. Nonpeptidic Z360-analogs tagged with trivalent radiometals as anti-CCK2R cancer theranostic agents: a preclinical study
Obeid et al. GRPR-antagonists carrying DOTAGA-chelator via positively charged linkers: perspectives for prostate cancer theranostics
NZ591824A (en) Butyrylcholinesterase ligands as diagnostic tools and treatment for deseases of the nervous system
Oxboel et al. 64Cu‐NODAGA‐c (RGDyK) Is a Promising New Angiogenesis PET Tracer: Correlation between Tumor Uptake and Integrin αVβ3 Expression in Human Neuroendocrine Tumor Xenografts
DE602007007362D1 (de) Radioaktiv markierte verbindungen auf peptidbasis und ihre verwendung
Peng et al. Exploring the Therapeutic Potential of 177Lu-PSMA-617 in a Mouse Model of Prostate Cancer Bone Metastases
González-Rueda et al. Theranostic potential of the iPSMA-bombesin radioligand in patients with metastatic prostate cancer: a pilot study

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties